NEW AWARD FOR MOXIFLOXACIN HCL OPHTHALMIC SOLUTION WITH GOLDEN STATE MEDICAL SUPPLY, INC. ORDERING PERIOD IS JUN 20, 2023 TO JUN 19, 2024 WITH FOUR ONE-YEAR OPTIONS. Solicitation ID/Procurement Identifier: 36E79723R0011 Ultimate Completion Date: Wed Jun 19 17:00:00 GMT 2024
Contract Opportunity Award Details General Information Classification Description Attachments/Links Contact Information History Award Notices Follow 6505--Moxifloxacin HCL Ophthalmic Solution (VA-23-00030038) Effective 6/20/2023 - 6/19/2024 Active Contract Opportunity Notice ID 36E79723R0011 Related Notice 36E79723R0011 Contract Line Item Number 1 Department/Ind.
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79718R0013 for an unrestrictive procurement for MOXIFLOXACIN OPHTHALMIC SOLUTION, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the
Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023.Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle
